| ARQT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ARQT shares outstanding history going back to 1/31/2020:
Also see: ARQT Market Cap History ARQT YTD Return |
ARQT Shares Outstanding History — Arcutis Biotherapeutics Share Count Over Time
As of 4/30/2026 Arcutis Biotherapeutics has 125.08 million ARQT shares outstanding. Investors often track the ARQT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ARQT share count trends over time, with 27 historical shares outstanding datapoints presented, dating back to 1/31/2020.
| ARQT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARQT Historical Shares Outstanding: +22.58% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ARQT Stock Price Chart |
| About Arcutis Biotherapeutics Inc |
| Arcutis Biotherapeutics, Inc. is a commercial-stage medical dermatology company. Co. is focused on developing and commercializing treatments for dermatological diseases with high-unmet medical needs. Its portfolio is comprised of topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. Its lead product, ZORYVE, is for the treatment of plaque psoriasis, including psoriasis in the intertriginous areas, in individuals 12 years of age or older. ZORYVE cream is a once-daily topical formulation of roflumilast, a potent and selective phosphodiesterase-4 (PDE4) inhibitor. Co.'s pipeline includes ARQ-255, ARQ-252, and ARQ-234. We show 27 historical shares outstanding datapoints in our coverage of ARQT's shares outstanding history. Understanding the changing numbers of ARQT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ARQT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ARQT by allowing them to research ARQT shares outstanding history as well as any other stock in our coverage universe. |
| ARQT Current Stock Quote |
Quotes delayed 20 minutes  Free ARQT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ARQT Share Performance |
| Shares Outstanding Peers |
| Arcutis Biotherapeutics (ARQT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ARTL Shares Outstanding History ARTV Shares Outstanding History ARVN Shares Outstanding History ARWR Shares Outstanding History ASMB Shares Outstanding History ASPI Shares Outstanding History ASRT Shares Outstanding History ASTH Shares Outstanding History ATAI Shares Outstanding History ATEC Shares Outstanding History More Healthcare companies » |
ARQT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
